Business Context and Reporting Period
PainReform Ltd. (PRF Technologies Ltd.) filed Form 6-K on May 16, 2022, to disclose its unaudited condensed financial statements and operating review for the three months ended March 31, 2022. The company is a foreign private issuer based in Tel Aviv, Israel, and files annual reports on Form 20-F.
Key Financial Metrics
The filing text serves as a cover document referencing attached exhibits (99.1 and 99.2) containing the detailed financial data. The text itself does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. Investors must refer to the attached exhibits for these figures.
Material Changes
The filing text does not contain specific data regarding material changes in financial performance compared to prior periods. Such analysis is contained within the referenced Operating and Financial Review (Exhibit 99.2).
Guidance, Outlook, and Risks
The filing text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies. These disclosures are located in the attached exhibits.
Investor Verification Checklist
- Review Exhibit 99.1 for the unaudited condensed balance sheet and income statement as of March 31, 2022.
- Examine Exhibit 99.2 for the operating and financial review to understand performance trends and liquidity status.
- Verify the company's cash position and burn rate given the lack of revenue disclosure in the cover text.
- Confirm the status of any ongoing regulatory or clinical developments mentioned in the full operating review.